{"database": "lobbying", "table": "lobbying_activities", "rows": [[988375, "384f7e53-8a23-4e1a-9dc4-df5da1cac110", "Q3", "CAPITOL COUNSEL LLC", 313715, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)", 2010, "third_quarter", "MMM", "Legislative issues related to access to pharmaceuticals, including Medicare Part D, and Children's Health Insurance Program (CHIP), rebates in Medicaid and for dual-eligibles; comparative effectiveness; 340B Drug Program and related provisions in HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2010-10-06T16:03:21.553000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["988375"], "units": {}, "query_ms": 41.16753302514553, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}